Rilpivirine, emtricitabine, and tenofovir vs Reverse Transcriptase Inhibitors (Non-Nucleoside)

Interacting Drugs
Rilpivirine, emtricitabine, and tenofovir
vs
Reverse Transcriptase Inhibitors (Non-Nucleoside)
Security Level
Major, Avoid combination
Mechanism
Reverse Transcriptase Inhibitors (Non-Nucleoside): May increase the serum concentration of Rilpivirine. This mechanism applies to coadministration of delavirdine. Reverse Transcriptase Inhibitors (Non-Nucleoside) may decrease the serum concentration of Rilpivirine. This mechanism applies to coadministration of efavirenz, etravirine, and nevirapine.
Management
Avoid combination

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Rilpivirine, emtricitabine, and tenofovir vs Reverse Transcriptase Inhibitors (Non-Nucleoside)


Other Interactions of Rilpivirine, emtricitabine, and tenofovir

We are Developing Our database, More results coming soon.

Other Interactions of Reverse Transcriptase Inhibitors (Non-Nucleoside)

We are Developing Our database, More results coming soon.